Lauxera HealthTech

The sector expertise of a HealthTech specialist combined with the experience of Pergam managers

The objective of the fund is to invest in the HealthTech sector to obtain a performance greater than Bloomberg World Large, Mid & Small Cap Net Return Index USD (WLSN index)

Investment Strategy

HealthTech brings together fast-growing companies in the medical sector that use new technologies to offer sustainable solutions for prevention and care, linking health care and innovation.

The complementarity of two experts: Lauxera, an expert company in the field of HealthTech, brings its in-depth knowledge of the sector. Pergam constructs the portfolio, optimises the investment timing and the weight of the positions.

The investment process:
Extensive private equity due diligence. A concentrated portfolio of approximately 30 stocks.

Sustainable finance:
Lauxera HealthTech is an SFDR Article 8 fund.

Lauxera HealthTech is a sub-fund of the Pergam Funds SICAV in compliance with the UCITS Directive.


VL €

( part IE )


VL €

( part RE )


VL $

( part IU )


VL $

( part RU )

AUM : 9.14 M€

Performance as of 22/05/2024 (PART IE)

No Data Found

First STOCKS lines in portfolio (as of 31/03/2024 )

No Data Found

Geographical distribution cash excluded (as of 31/03/2024 )

No Data Found

Importante information : the figures quoted relate to past years and past performance is not a reliable indicator of future performance. They are not constant over time and not guaranteed. The fund may not be suitable for all investors. The risks and costs associated with investing in the fund are described in the KIID (key investor information presentation) and in the prospectus, which can be downloaded from the website Pergam invites the persons concerned to read them. The KIID must be given to the investors prior to subscription. The tax treatment depends about each client and may be modified subsequently Source: Bloomberg Index Services Limited. BLOOMBERG® and the indices referenced herein (the “Indices”, and each such index, an “Index”) are service marks of Bloomberg Finance L.P. and its affiliates (collectively “Bloomberg”) and/or one or more third-party providers (each such provider, a “Third-Party Provider,”) and have been licensed for use for certain purposes to PERGAM SAS (the “Licensee”). To the extent a Third-Party Provider contributes intellectual property in connection with the Index, such third-party products, company names and logos are trademarks or service marks, and remain the property, of such Third-Party Provider. Bloomberg or Bloomberg’s licensors own all proprietary rights in the Bloomberg Indices. Neither Bloomberg nor Bloomberg’s licensors, including a Third-Party Provider, approves or endorses this material, or guarantees the accuracy or completeness of any information herein, or makes any warranty, express or implied, as to the results to be obtained therefrom and, to the maximum extent allowed by law, neither Bloomberg nor Bloomberg’s licensors, including a Third-Party Provider, shall have any liability or responsibility for injury or damages arising in connection therewith.

Our other

Pergam Global Fund
Flexible and international management.

Pergam Active Dividend
Yield values in the European context.

Pergam Best Holdings
Investing in listed holding companies, managed by entrepreneurs and teams with a proven track record.

Software Conviction Fund
The sectorial expertise of a software specialist combined with the experience of Pergam's managers.



Amel joined PERGAM in 2021 after 8 years of experience in the field of customer care.

Amel holds a BTS in accounting.

Welcome to the Pergam website

This site is an information site with the objective of presenting Pergam’s portfolio management activity as well as the main characteristics of its UCIs and services. It does not constitute a canvassing activity, an offer of securities or a public offering.

Access to the products and services presented on the site may be subject to restrictions with regard to certain persons, and in particular non-professional clients in accordance with the provisions of Article L.533 of the French Monetary and Financial Code and Directive 2004/39/EC on markets in financial instruments, or certain countries, and in particular with regard to investors in the United States who are subject to specific legislation. In addition, the products and services presented on this site may only be purchased in jurisdictions where they are authorised to be marketed and promoted.

If you are interested in any of the services or UCIs presented on this site, we advise you to ensure that you are legally entitled to subscribe to them. The information on the site is provided for information purposes only and does not release the user from undertaking additional and personalised analysis.

This site, and all the information presented on it, are governed by French law. Certain laws prohibit or restrict access to this site. We therefore ask you to ensure that you are legally entitled to connect to it in the country from which the connection is made.

To return to the home page of this site, click ‘Continue’.